- Home
- BGM vs NBXG Comparison
BGM vs NBXG Comparison
Compare BGM & NBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGM
- NBXG
- Stock Information
- Founded
- BGM 2019
- NBXG 2021
- Country
- BGM China
- NBXG United States
- Employees
- BGM N/A
- NBXG N/A
- Industry
- BGM
- NBXG Trusts Except Educational Religious and Charitable
- Sector
- BGM
- NBXG Finance
- Exchange
- BGM NYSE
- NBXG Nasdaq
- Market Cap
- BGM 962.5M
- NBXG 989.2M
- IPO Year
- BGM 2021
- NBXG N/A
- Fundamental
- Price
- BGM $11.35
- NBXG $12.37
- Analyst Decision
- BGM
- NBXG
- Analyst Count
- BGM 0
- NBXG 0
- Target Price
- BGM N/A
- NBXG N/A
- AVG Volume (30 Days)
- BGM 25.7K
- NBXG 243.7K
- Earning Date
- BGM 04-08-2025
- NBXG 01-01-0001
- Dividend Yield
- BGM N/A
- NBXG 10.25%
- EPS Growth
- BGM N/A
- NBXG N/A
- EPS
- BGM N/A
- NBXG N/A
- Revenue
- BGM $25,097,951.00
- NBXG N/A
- Revenue This Year
- BGM N/A
- NBXG N/A
- Revenue Next Year
- BGM N/A
- NBXG N/A
- P/E Ratio
- BGM N/A
- NBXG N/A
- Revenue Growth
- BGM N/A
- NBXG N/A
- 52 Week Low
- BGM $2.70
- NBXG $9.31
- 52 Week High
- BGM $14.78
- NBXG $12.23
- Technical
- Relative Strength Index (RSI)
- BGM 59.03
- NBXG 40.40
- Support Level
- BGM $10.31
- NBXG $12.17
- Resistance Level
- BGM $11.90
- NBXG $12.60
- Average True Range (ATR)
- BGM 1.00
- NBXG 0.25
- MACD
- BGM 0.17
- NBXG 0.04
- Stochastic Oscillator
- BGM 65.69
- NBXG 46.60
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in "NextGen Companies".